Subscribe to Newsletter

Content by James Strachan:

Discovery & Development Drug Delivery

Placental Payloads

| James Strachan

Tumor cells and phages inspire a new drug delivery method targeting the placenta

Business & Regulation Business Practice

The Great British Debate

| James Strachan

As politicians and the public argue over the minor point of the UK leaving Europe, we ask a more important question: what will a “Brexit” mean for the global pharmaceutical industry?

Discovery & Development Analytical Science

Cancer Static Shock

| James Strachan

Are the metrics used to measure cancer drug efficacy inherently flawed?

Manufacture Small Molecules

Space Biology Awakens

| James Strachan

Can the stress of space force fungi to produce novel therapeutics?

Business & Regulation Business Practice

CSRxP Vs PhRMA

| James Strachan

A US coalition seeks lower prices for US prescription drugs, but could their proposals undermine the competitive market?

Business & Regulation Business Practice

Pharma on a Merger Mission

| James Strachan

Abbott, Abbvie and Sanofi all make separate merger announcements – on the same day

Business & Regulation Business Practice

Getting the Message Across

| James Strachan

What’s the best way to present a health resource? Apparently, ease of use trumps all other factors

Business & Regulation Business Practice

Hive of Industry

| James Strachan

Are you a budding biotech or pharma startup? “The Hive” could be your chance to showcase your work

Discovery & Development Drug Delivery

Microparticles, You’ve Been Thunderstruck

| James Strachan

Scientists use hydrophobic plasma and AC/DC’s ‘Thunderstruck’ to coat porous silicon microparticles for drug delivery

Manufacture Small Molecules

Moving from Batch to Continuous

| James Strachan

The first switch from batch to continuous manufacturing has been made – and approved by the FDA. Will pharma’s future be continuous?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register